Kashif N. Ather

Kashif Ather practices at Vassar Brothers Medical Center (Legacy Hospital - Building B) in Poughkeepsie, New York.

Kashif Ather's NPI, 1619355591, was assigned on May 12, 2015. Kashif Ather graduated from University of Connecticut in 2015. Kashif Ather holds New York license 308581.

Kashif Ather's primary practice is Vassar Brothers Medical Center (Legacy Hospital - Building B), at 45 Reade Pl, Poughkeepsie, NY 12601 in Dutchess County. The practice phone is (845) 483-6604.

Kashif Ather's primary practice is Vassar Brothers Medical Center (Legacy Hospital - Building B) in Poughkeepsie, New York. Kashif Ather is also affiliated with Vassar Brothers Medical Center. The medical group on file is The Heart Center. Dmand AI also links Kashif Ather to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kashif Ather practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Kashif Ather's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Kashif Ather's licenses on file in 2 states: New York and Rhode Island.

CMS data shows 3,418 Medicare services from Kashif Ather across 26 procedure codes in 2024, for 1,409 Medicare patients. Medicare paid $201,213 for them.

CMS counts 1,409 Medicare patients who saw Kashif Ather in 2024. The largest group is 75 to 84, with 539 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kashif Ather's median patient age at 72, with 46% women.

In 2024, Kashif Ather wrote 2,995 Medicare Part D claims for 646 patients. 86% of them were for generic drugs. CMS names the drug for 2,819 of them, across 37 drugs with 11 or more claims each, at $457,234 in total drug cost. In 2023, CMS named 2,152 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Kashif Ather for performance year 2024, reported as part of a group. Kashif Ather accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kashif Ather as offering telehealth.

Dmand AI links 5 papers to Kashif Ather, published from 2018 to 2023. 2021 was the busiest year, with 2. Kashif Ather has published most often in Curr Probl Cardiol. Kashif Ather's most frequent co-authors are Olushola Olaitan Ogunleye, MD, Akanimo Antia, MD and Herbert David Aronow, MD.

CMS Open Payments shows 18 general payments to Kashif Ather from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 50% of the total. Edwards Lifesciences Corporation paid the most, $971.

Kashif Ather graduated from University of Connecticut in 2015.